ATE529125T1 - Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung - Google Patents

Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung

Info

Publication number
ATE529125T1
ATE529125T1 AT04745067T AT04745067T ATE529125T1 AT E529125 T1 ATE529125 T1 AT E529125T1 AT 04745067 T AT04745067 T AT 04745067T AT 04745067 T AT04745067 T AT 04745067T AT E529125 T1 ATE529125 T1 AT E529125T1
Authority
AT
Austria
Prior art keywords
methods
pharmaceutical compositions
wound healing
accelerating wound
accelerating
Prior art date
Application number
AT04745067T
Other languages
English (en)
Inventor
Liora Braiman-Wiksman
Innesa Solomonik
Original Assignee
Healor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healor Ltd filed Critical Healor Ltd
Application granted granted Critical
Publication of ATE529125T1 publication Critical patent/ATE529125T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04745067T 2003-08-07 2004-08-05 Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung ATE529125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49300003P 2003-08-07 2003-08-07
PCT/IL2004/000727 WO2005013885A2 (en) 2003-08-07 2004-08-05 Pharmaceutical compositions and methods for accelerating wound healing

Publications (1)

Publication Number Publication Date
ATE529125T1 true ATE529125T1 (de) 2011-11-15

Family

ID=34135191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04745067T ATE529125T1 (de) 2003-08-07 2004-08-05 Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung

Country Status (13)

Country Link
US (4) US7638484B2 (de)
EP (1) EP1651161B1 (de)
JP (2) JP4668902B2 (de)
CN (2) CN102120031B (de)
AT (1) ATE529125T1 (de)
AU (1) AU2004263009B2 (de)
CA (1) CA2535029C (de)
DK (1) DK1651161T3 (de)
ES (1) ES2375565T3 (de)
NZ (1) NZ545086A (de)
RU (2) RU2358753C2 (de)
WO (1) WO2005013885A2 (de)
ZA (1) ZA200601089B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
DK1651161T3 (da) * 2003-08-07 2012-01-30 Healor Ltd Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
AU2004287376A1 (en) * 2003-10-09 2005-05-19 Trustees Of Boston University Methods and compositions using adiponectin for treatment of cardiac disorders and for stimulation of angiogenesis
EP2298863B1 (de) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymale Stammzellen und deren Verwendungen
JP2006230316A (ja) * 2005-02-25 2006-09-07 Japan Health Science Foundation 瘢痕のない創傷治癒能を有する細胞およびその調製方法
EP2452686A3 (de) 2005-08-29 2012-09-05 HealOr Ltd. Verfahren und Zusammensetzungen zur Vorbeugung und Behandlung von diabetischer und alternder Haut
KR100888889B1 (ko) 2007-07-24 2009-03-17 부산대학교 산학협력단 비스파틴을 유효성분으로 함유하는 혈관신생 촉진제
CN101835486B (zh) * 2007-07-30 2012-12-12 希尔洛有限公司 用于治疗创伤的药物组合物以及相关方法
AU2008289461A1 (en) * 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
WO2009045370A2 (en) 2007-09-28 2009-04-09 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
KR101361416B1 (ko) 2008-10-08 2014-02-21 인트렉손 코포레이션 다수의 면역조절자를 발현하는 조작된 세포 및 그 용도
AU2010235334A1 (en) * 2009-04-06 2011-11-24 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition for treating or preventing burn injuries
US8173154B2 (en) * 2010-01-06 2012-05-08 The Curators Of The University Of Missouri Boron trioxide glass-based fibers and particles in dressings, sutures, surgical glue, and other wound care compositions
EP2523677A2 (de) 2010-01-11 2012-11-21 Healor Ltd. Verfahren zur behandlung von entzündungskrankheiten und -erkrankungen
US20120264681A1 (en) * 2010-11-08 2012-10-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
AU2013203164B8 (en) * 2011-03-15 2014-11-20 Cell Ideas Pty Ltd Therapeutics for skin conditions
AU2015202776B2 (en) * 2011-03-15 2017-08-17 Cell Ideas Pty Ltd Pharmaceutical compositions and topical use thereof
EP2685993B9 (de) 2011-03-15 2017-04-05 Cell Ideas Pty Ltd. Zusammensetzung enthaltend aus Fettgewebe stammenden Sekretionen zur topische Behandlung und Vorbeugung von Akne
US20140220598A1 (en) * 2011-09-09 2014-08-07 Tohoku University Biological substance detection method
WO2014000029A1 (en) 2012-06-26 2014-01-03 Rusty Property Holdings Pty Ltd Compositions and methods for reducing frequency and/or severity of headache
JP6113981B2 (ja) * 2012-06-29 2017-04-12 ポーラ化成工業株式会社 スクリ−ニング方法
KR101588394B1 (ko) 2013-05-09 2016-01-25 라정찬 줄기세포의 재생능 향상을 위한 배지 조성물 및 이를 이용한 줄기세포의 배양방법
BR112016022455B1 (pt) 2014-03-31 2021-03-16 Lubrizol Advanced Materials, Inc uso de um sobrenadante de culturas de uma cepa de espécies de bacillus pumilus, composição cosmética ou dermofarmacêutica não natural, e, método não terapêutico para aumentar os níveis de adiponectina, aumentar a atividade mitocondrial no músculo, aumentar a resistência muscular e/ou repitelização da pele, estimular a síntese de colágeno e/ou a síntese de ácido hialurônico, tratamento de endurecimento da pele e/ou prevenção da perda de firmeza da pele
KR20160010212A (ko) 2014-07-18 2016-01-27 주식회사 젬백스앤카엘 항노화 및 창상 치료용 펩티드 및 이를 포함하는 조성물
EP3090764A1 (de) * 2015-05-08 2016-11-09 Université Catholique De Louvain Zusammensetzungen mit mesenchymalen stammzellen und verwendungen davon
US10471122B2 (en) * 2015-07-31 2019-11-12 Blue Blood Biotech Corp. Composition for use in promoting wound healing
WO2017027353A1 (en) * 2015-08-07 2017-02-16 The Johns Hopkins University Compositions and methods for modulating wound healing and regeneration
EP3132809A1 (de) 2015-08-21 2017-02-22 Bioskinco GmbH Zusammensetzung und produkte mit alterungszellen zur geweberegeneration
US20170216479A1 (en) 2016-01-28 2017-08-03 University Of Maryland, College Park Compositions comprising textured patterns and methods of using the same
CA3017816C (en) * 2016-03-24 2023-04-25 Stemlab, Sa Use of umbilical cord blood derived exosomes for tissue repair
CN106177919A (zh) * 2016-07-28 2016-12-07 广州赛莱拉干细胞科技股份有限公司 一种改善伤口愈合的脂肪制剂及其制备方法
CN106215172A (zh) * 2016-07-28 2016-12-14 广州赛莱拉干细胞科技股份有限公司 一种改善伤口愈合的脂肪制剂及其制备方法
EP3595680A1 (de) 2017-03-17 2020-01-22 Rutgers, The State University of New Jersey Zusammensetzungen und verfahren zur wundheilung
RU2663907C1 (ru) * 2017-05-04 2018-08-13 Ринат Маратович Урузбаев Способ ускорения заживления кожных повреждений
CN113491696A (zh) * 2017-07-05 2021-10-12 江阴优培尔康药业有限公司 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂
RU2687007C2 (ru) * 2017-09-12 2019-05-06 Общество с ограниченной ответственностью "Клеточные Системы" Способ биотехнологического восстановления кожного покрова аллогенными стволовыми клетками человека
CN109876012B (zh) * 2019-03-21 2022-01-11 北京隆祺生物科技有限公司 一种药用组合物及其在促进皮肤伤口愈合中的应用
CN113304174A (zh) * 2020-03-30 2021-08-27 大树医疗美容科技(广州)有限公司 一种人体脂肪细胞分泌的培养液提取物
US12599698B2 (en) * 2021-10-28 2026-04-14 Kismet Technologies Inc. Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control
US12252629B2 (en) 2021-10-28 2025-03-18 Kismet Technologies Inc. Electronic device with self-disinfecting touch screen and method of manufacture
CN118121578B (zh) * 2024-05-06 2024-08-16 广州市朝利良生物科技有限公司 化合物eh-p008v及在制备促伤口愈合药物中的应用

Family Cites Families (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2001A (en) * 1841-03-12 Sawmill
US2003A (en) * 1841-03-12 Improvement in horizontal windivhlls
US200A (en) * 1837-05-22 Geoege
GB280460A (en) 1927-06-10 1927-11-17 George Percival Milnes Improvements in mouthpieces for tobacco pipes and other tubes
US3549747A (en) 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
US3947573A (en) 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3856919A (en) 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3767788A (en) 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
US3767789A (en) 1971-06-21 1973-10-23 Burton Parsons & Co Inc Method of providing a synthetic mucus in vivo
US3907985A (en) 1973-07-27 1975-09-23 Burton Parsons And Company Inc Polystyrene sulfonate containing opthalmic solutions
US3987163A (en) 1973-07-27 1976-10-19 Burton, Parsons And Company, Inc. Polystyrene sulfonate containing opthalmic solutions
US4029817A (en) 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
US3920810A (en) 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US4120949A (en) 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4558033A (en) * 1983-06-06 1985-12-10 Amgen Potentiation of the effects of insulin by peptides
US4673649A (en) 1983-07-15 1987-06-16 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
AU4292585A (en) 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
US5110801A (en) 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4843096A (en) 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
DE3674883D1 (de) 1985-11-25 1990-11-15 Wako Pure Chem Ind Ltd Farbentwicklungsmethode in klinischen untersuchungen.
US4833257A (en) 1986-07-28 1989-05-23 Arizona Board Of Regents Compositions of matter and methods of using same
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
JPH0739508B2 (ja) * 1986-11-11 1995-05-01 株式会社林原生物化学研究所 プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
US4885163A (en) 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
US5700450A (en) 1988-03-30 1997-12-23 The Trustees Of Boston University Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof
ZA892928B (en) 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US5137734A (en) * 1989-03-22 1992-08-11 Dana Farber Cancer Institute Angiogenic monoglycerides
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5158935A (en) * 1989-05-12 1992-10-27 Chiron Corporation Human epidermal growth factor having substitution at position 11
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US5145679A (en) 1989-10-05 1992-09-08 Hinson Joan B Topical emollient for prevention and treatment of circulatory induced lesions
US5423778A (en) * 1989-12-14 1995-06-13 Elof Eriksson System and method for transplantation of cells
US5981606A (en) 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
SK108293A3 (en) 1991-04-11 1994-09-07 Schering Corp Anti-tumor and anti-psoriatic agents
WO1992018147A1 (en) 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US5591709A (en) 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
HUT67319A (en) 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
AU3062392A (en) 1991-11-04 1993-06-07 Novo Nordisk A/S Pdgf gel formulation
US6537973B1 (en) 1992-03-16 2003-03-25 Isis Pharmaceuticals, Inc. Oligonucleotide inhibition of protein kinase C
DE4208552A1 (de) 1992-03-17 1993-09-23 Liedtke Pharmed Gmbh Topische arzneiformen mit insulin
GB9210574D0 (en) 1992-05-18 1992-07-01 Ca Nat Research Council Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
CA2125060C (en) 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
CA2147810A1 (en) 1994-04-25 1995-10-26 Susumu Yoshida Biologically active substance-secreting hybrid gel
US6028118A (en) 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
JP3414539B2 (ja) 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
RU2198900C2 (ru) 1994-05-24 2003-02-20 Еда Рисерч энд Дивелопмент Ко., Лтд. Усовершенствованный сополимер-1 и способ его получения
ATE350053T1 (de) 1994-12-29 2007-01-15 Ferring Int Ct Sa Herstellung von humaninsulin
AUPN089295A0 (en) 1995-02-02 1995-03-02 International Diabetes Institute Treatment of diabetic neuropathy
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
US6153380A (en) 1996-01-23 2000-11-28 Rigel Pharmaceuticals, Inc. Methods for screening for transdominant intracellular effector peptides and RNA molecules
US5869037A (en) * 1996-06-26 1999-02-09 Cornell Research Foundation, Inc. Adenoviral-mediated gene transfer to adipocytes
JPH10158188A (ja) 1996-11-29 1998-06-16 Senju Pharmaceut Co Ltd 角膜治療用組成物
GB9702943D0 (en) 1997-02-13 1997-04-02 Univ Manchester Wound healing
WO1999018920A1 (en) 1997-10-16 1999-04-22 Deguang Zhu A new powerful cosmetic or pharmaceutical composition
AU3635099A (en) 1997-12-15 1999-07-26 Beth Israel Deaconess Medical Center Methods and reagents for modulating cell motility
US6274712B1 (en) * 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
FR2773075B1 (fr) 1997-12-31 2000-05-05 Cird Galderma Utilisation d'activateurs de ppar-gamma en dermatologie
DE69924232D1 (de) * 1998-01-09 2005-04-21 Novo Nordisk As Stabilisierte insulin-zubereitungen
US6790207B2 (en) 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US6489306B2 (en) 1998-02-23 2002-12-03 University Of South Florida Method of intranasal gene transfer for protection against respiratory infection
US6335201B1 (en) 1998-03-06 2002-01-01 The Regents Of The University Of California Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility
AU760664B2 (en) * 1998-04-17 2003-05-22 Angiogenix, Inc. Therapeutic angiogenic factors and methods for their use
AU4672199A (en) * 1998-05-20 1999-12-06 Yale University Modulation of angiogenesis and wound healing
US6376467B1 (en) * 1998-10-09 2002-04-23 The Regents Of The University Of California Use of inhibitors of protein kinase C epsilon to treat pain
WO2000005250A1 (en) 1998-07-23 2000-02-03 Yeda Research And Development Co., Ltd Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
EP2090583B1 (de) 1998-09-25 2011-07-13 Yeda Research And Development Co., Ltd. Mit Copolymer 1 verwandte Polypeptide zur Verwendung als Molekulargewichtsmarker und zur therapeutischen Verwendung
US6096288A (en) 1998-10-12 2000-08-01 Mobil Oil Corporation Synthesis of the cubic mesoporous molecular sieve MCM-48
WO2000030628A2 (en) 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
HK1042648A1 (zh) 1999-04-14 2002-08-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, C/O National Institutes Of Health, Office Of Technology Transfer 用於诱导对移植物的免疫耐受的含有免疫毒素和抑制树突细胞成熟的试剂的组合物
US7261881B1 (en) * 1999-05-20 2007-08-28 Yale University Modulation of angiogenesis and wound healing
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
EP1259595B1 (de) 2000-02-25 2007-04-04 Immunex Corporation Integrin antagonisten
JP2003528926A (ja) 2000-03-24 2003-09-30 ノバルティス アクチエンゲゼルシャフト 新血管形成の改善された処置
EP1272231A1 (de) 2000-04-06 2003-01-08 University Technology Corporation Zusammensetzungen und verfahren zur förderung der wundheilung
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
DE60138572D1 (de) 2000-07-31 2009-06-10 Univ Bar Ilan Methoden und pharmazeutische zusammensetzungen zur wundheilung
US20030148924A1 (en) 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
US20100129332A1 (en) 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US6673603B2 (en) 2000-09-01 2004-01-06 Modex Therapeutiques, S.A. Cell paste comprising keratinocytes and fibroblasts
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US20020119914A1 (en) 2000-12-26 2002-08-29 Deguang Zhu New uses of insulin and pancreatin
JP2002198443A (ja) 2000-12-26 2002-07-12 Nec Corp 半導体装置及びその製造方法
GB0103877D0 (en) 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
DE10109280A1 (de) 2001-02-26 2002-09-05 Peter Mayser Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen
US6750234B2 (en) * 2001-03-08 2004-06-15 University Of Kentucky Research Foundation Methods for increasing leptin levels using nicotinic acid compounds
KR100404072B1 (ko) 2001-03-12 2003-11-03 주식회사 두산 광범위 피부질환 치료용 조성물
JP2002272831A (ja) 2001-03-14 2002-09-24 Fumio Kamiyama 創傷被覆用粘着性シート
WO2002087576A1 (en) 2001-04-30 2002-11-07 Arachnova Therapeutics Ltd. The treatment of scarring and related conditions using ppar-gamma activators
WO2002094877A2 (en) 2001-05-23 2002-11-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) New nuclear receptor cofactors and related modulators
ES2184623B1 (es) 2001-06-29 2004-09-16 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) Piel artificial autologa secretora de leptina y metodo de obtencion.
US20030124503A1 (en) 2001-12-28 2003-07-03 Olivencia-Yurvati Albert H. Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
WO2003059396A1 (en) * 2002-01-11 2003-07-24 Sergei Zolotukhin Adiponectin gene therapy
RU2249467C2 (ru) 2002-11-25 2005-04-10 ООО Научно-производственное предприятие "ЭРЛОН", Лтд. Медицинский материал и изделия на его основе
US20040175384A1 (en) 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
NZ573737A (en) * 2003-07-15 2011-06-30 Univ Bar Ilan Methods and pharmaceutical compositions for healing wounds comprising a PKC modulator
AU2004259000A1 (en) 2003-07-21 2005-02-03 Bethesda Pharmaceuticals, Inc. Design and synthesis of optimized ligands for PPAR
DK1651161T3 (da) * 2003-08-07 2012-01-30 Healor Ltd Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
EP2228069A1 (de) 2003-09-16 2010-09-15 Garvan Institute Of Medical Research Antagonisten der Protein Kinase C-Epsilon (pkcepsilon) und deren Anwendungen für die Behandlung von damit im Zusammenhang stehenden aberranten Glukosestoffwechsel
KR20060127415A (ko) 2003-12-24 2006-12-12 와이어쓰 천식의 치료방법
WO2006086681A2 (en) 2005-02-09 2006-08-17 Beth Israel Deaconess Medical Center, Inc. Methods of inhibiting smooth muscle cell migration and proliferation
WO2006108270A1 (en) 2005-04-11 2006-10-19 Pharmagap Inc. Inhibitors of protein kinases and uses thereof
US20110039770A1 (en) 2005-08-05 2011-02-17 Pharmagap Inc. Inhibitors of protein kinase c isoforms and uses thereof
EP2452686A3 (de) 2005-08-29 2012-09-05 HealOr Ltd. Verfahren und Zusammensetzungen zur Vorbeugung und Behandlung von diabetischer und alternder Haut
US20090306045A1 (en) 2005-12-22 2009-12-10 Ira Mellman Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease
WO2008026018A1 (en) 2006-09-01 2008-03-06 Topotarget Switzerland Sa New method for the treatment of inflammatory diseases
US20080292726A1 (en) 2007-01-23 2008-11-27 Bernstein Lawrence R Ophthalmic gallium compositions and methods of their use
CN101835486B (zh) 2007-07-30 2012-12-12 希尔洛有限公司 用于治疗创伤的药物组合物以及相关方法
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
CN102186822A (zh) 2008-08-29 2011-09-14 顶标公司 新脲和硫脲衍生物
US20110223177A1 (en) 2008-09-09 2011-09-15 University Of East Anglia Treatment of fibrotic eye disorders
CN102325789A (zh) 2009-02-24 2012-01-18 希尔洛有限公司 用于治疗痤疮和其它病症的内脂素治疗药物
EP2523677A2 (de) 2010-01-11 2012-11-21 Healor Ltd. Verfahren zur behandlung von entzündungskrankheiten und -erkrankungen

Also Published As

Publication number Publication date
EP1651161A4 (de) 2009-09-09
WO2005013885A2 (en) 2005-02-17
CN101287483A (zh) 2008-10-15
JP2007512226A (ja) 2007-05-17
RU2009103919A (ru) 2010-08-20
ZA200601089B (en) 2007-05-30
DK1651161T3 (da) 2012-01-30
ES2375565T3 (es) 2012-03-02
HK1091400A1 (en) 2007-01-19
US20140148389A1 (en) 2014-05-29
CN101287483B (zh) 2012-02-29
US7638484B2 (en) 2009-12-29
JP2011068663A (ja) 2011-04-07
US8507431B2 (en) 2013-08-13
RU2358753C2 (ru) 2009-06-20
HK1156515A1 (en) 2012-06-15
CN102120031A (zh) 2011-07-13
RU2006106909A (ru) 2006-09-10
NZ545086A (en) 2011-06-30
CA2535029A1 (en) 2005-02-17
WO2005013885A3 (en) 2008-05-02
US20120020917A1 (en) 2012-01-26
AU2004263009A1 (en) 2005-02-17
JP4668902B2 (ja) 2011-04-13
EP1651161A2 (de) 2006-05-03
RU2419441C2 (ru) 2011-05-27
CN102120031B (zh) 2012-12-05
US20060177418A1 (en) 2006-08-10
AU2004263009B2 (en) 2009-12-24
US20080159978A1 (en) 2008-07-03
CA2535029C (en) 2013-07-16
EP1651161B1 (de) 2011-10-19

Similar Documents

Publication Publication Date Title
EP1651161A4 (de) Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
EA200802365A1 (ru) Аминометилзамещенные тетрациклиновые соединения
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
ATE455463T1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
ATE498395T1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
ATE450251T1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE497763T1 (de) Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
HRP20080617T3 (en) Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin
ATE478156T1 (de) Verfahren zur identifizierung von modulatoren der eoxin-bildung
ATE495735T1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
ATE439831T1 (de) Stabile kristalline form von bifeprunoxmesylat, dosierungsformen davon und verfahren zu deren verwendung
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
ATE439125T1 (de) Fenofibrate tablett und verfahren zur herstellung
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
BRPI0507157A (pt) uso de fator viia ou de um equivalente de fator viia, kit de partes para tratamento de trauma, e, métodos para tratar trauma e para prevenir, tratar trauma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1651161

Country of ref document: EP